Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page version rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-27T06:18:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now shown on the page, replacing v3.6.2, indicating an internal version update to the page metadata.
    Difference
    0.0%
    Check dated 2026-07-05T11:01:19.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.0 to v3.6.2, indicating a newer page version has been published.
    Difference
    0.0%
    Check dated 2026-06-28T08:17:34.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Adds recruitment-status notice and new user guidance sections, and updates the Intervention/Treatment label and revision version, while removing the older revision label.
    Difference
    0.1%
    Check dated 2026-06-13T17:50:30.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page template.
    Difference
    0.0%
    Check dated 2026-06-06T14:19:10.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, and the old AstraZeneca study locator contact block was removed.
    Difference
    0.0%
    Check dated 2026-05-15T23:59:17.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.